Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

CEO James Mullen's Departure from Biogen Idec: The Good, the Bad and the Ugly
BNET Pharma
Thursday, January 7, 2010 - 10:18am
tags:
Biogen Idec, James Mullen
Novartis to Buy Aclon: Will the Gurus Sell?
Seeking Alpha
Thursday, January 7, 2010 - 10:01am
tags:
Novartis, Alcon, M&A
Pfizer enters melanoma partnership with Debiopharm
Yahoo/AP
Thursday, January 7, 2010 - 10:00am
tags:
Pfizer, Debiopharm, melanoma, partnerships
ZymoGenetics selling 12M shares of stock to raise $80M
Bizjournals.com
Thursday, January 7, 2010 - 10:00am
tags:
stock offering, ZymoGenetics
Biogen discloses more PML cases
Bizjournals.com
Thursday, January 7, 2010 - 9:57am
tags:
PML, Biogen Idec, Tysabri
Teva, AstraZeneca end dispute on Prilosec, Nexium
Marketwatch
Thursday, January 7, 2010 - 9:56am
tags:
Prilosec, Nexium, generics, Teva Pharmaceuticals, AstraZeneca
Gilead Goes It Alone ... for Now
Motley Fool
Thursday, January 7, 2010 - 9:55am
tags:
Gilead Sciences, HIV, Quad
Lundbeck Faces EU Antitrust Probe Into Generic Sales
Bloomberg
Thursday, January 7, 2010 - 9:54am
tags:
Lundbeck, antitrust, generics, antidepressants, Europe
Amgen’s, J&J’s Anemia Drugs Face FDA Advisory Review on Dose
Bloomberg
Thursday, January 7, 2010 - 9:52am
tags:
FDA, anemia, Amgen, Aranesp, Epogen, Procrit, JNJ
MannKind shares gain ground ahead of FDA decision
Yahoo/AP
Thursday, January 7, 2010 - 9:51am
tags:
FDA, MannKind, inhaled insulin, Afresa
What Merck’s CEO Said Today About Possible Job Cuts
WSJ Online
Wednesday, January 6, 2010 - 4:04pm
tags:
Merck, Pharma CEOs, layoffs, reorganization, Richard Clark
Still Fixing Pfizer
CNBC
Wednesday, January 6, 2010 - 4:03pm
tags:
Pfizer, Jeff Kindler
Glaxo restructures HR with job, cost cuts
Fierce Pharma
Wednesday, January 6, 2010 - 11:24am
tags:
GSK, restructuring
Vultures Descend and Phoenixes Rise in the Wake of Biotech Consolidation
BNET Pharma
Wednesday, January 6, 2010 - 11:23am
tags:
consolidation, M&A, biotech
Daiichi Sankyo' Subsidiary Acquires PharmaForce
Pharmaceutical Business Review
Wednesday, January 6, 2010 - 11:12am
tags:
PharmaForce, Daiichi Sankyo, M&A, Luitpold
Drug stocks inch up; Gilead gains on HIV study
Marketwatch
Wednesday, January 6, 2010 - 11:06am
tags:
drug stocks, HIV, Gilead Sciences
Pfizer and Strides Arcolab to Collaborate on Generic Products
Yahoo
Wednesday, January 6, 2010 - 10:49am
tags:
generics, Pfizer, Strides Arcolab, partnerships
Celgene's 2010 Guidance Key Event Next Week
TheStreet.com
Wednesday, January 6, 2010 - 10:48am
tags:
Celgene, guidance
Which Drugs Have The Biggest Pre-Tax Margins?
Pharmalot
Wednesday, January 6, 2010 - 10:46am
tags:
Pfizer, AstraZeneca, Novartis, Eli Lilly, Roche, Sanofi, Bristol-Myers Squibb
‘Salami Slicing’ Promoted Lilly’s Cymbalta: Study
Pharmalot
Wednesday, January 6, 2010 - 10:44am
tags:
Cymbalta, Eli Lilly, antidepressants

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.